Ketoconazole attenuates the cortisol response but not the subjective effects of smoked cocaine in humans

Behavioural Pharmacology

Volumn 9, Issue 7, 1998, Pages 577-586

  Ward, A S ^a   Collins, E D ^a   Haney, M ^a   Foltin, R W ^a   Fischman, M W ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

ACTH; Cardiovascular effects; Cortisol; Humans; Ketoconazole; Subjective effects

Indexed keywords

COCAINE; CORTICOTROPIN; HYDROCORTISONE; KETOCONAZOLE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID METABOLISM; CORTICOTROPIN RELEASE; DOSE RESPONSE; DRUG ABUSE; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INHALATIONAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; SINGLE BLIND PROCEDURE;

EID: 0031798067     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199811000-00013     Document Type: Article

References (38)

1. Baumann MH, Gendron TM, Becketts KM, Henningfield JE, Gorelick DA, Rothman RB (1995). Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers. Biol Psychiatry 38:751-755.
2. Calogero AE, Gallucci WT, Kling MA, Chrousos GP, Gold PW (1989). Cocaine stimulates rat hypothalamic corticotropin-releasing hormone in vitro. Brain Res 505:7-11.
3. Cintra A, Zoli M, Rosen L, Agnati LF, Okret S, Wikstrom AC, Gustafsson JA (1994). Microdensitometry of glucocorticoid receptor immunoreactive neurons in the rat central nervous system. Neuroscience 62:843-897.
4. Deroche V, Marinelli M, Le Moal M, Piazza PV (1997). Glucocorticoids and behavioral effects of psychostimulants. II: cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels. J Pharmacol Exp Ther 281:1401-1407.
5. Deroche V, Piazza P, Deminiere JM, Le Moal M, Simon H (1993). Rats orally self-administer corticosterone. Brain Res 622:315-320.
6. Dixon RB, Christy NP (1980). On the various forms of corticosteroid withdrawal syndrome. Am J Med 68:224-230.
7. Engelhardt D, Dorr G, Jaspers, C, Knorr D (1985). Ketoconazole blocks cortisol in man by inhibition of adrenal 11β-hydroxylase. Klin Wochenshcrift 63:607-612.
8. Fischman MW (1989). Relationship between self-reported drug effects and their reinforcing effects: Studies with stimulant drugs. In: Testing for abuse liability of drugs in humans. National Institute of Drug Abuse Research Monograph Series 92. Fischman MW, Mello NK (editors). Washington, DC: US Government Printing Office, pp. 211-230.
9. Foltin RW, Fischman MW (1991). Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 257:247-261.
10. Foltin RW, Fischman MW, Nestadt G, Stromberger H, Cornell EE, Pearlson GD (1990). Demonstration of naturalistic methods for cocaine smoking by human volunteers. Drug Alcohol Depend 26:145-154.
11. Fowler JS, Volkow ND, Wolf AD, Dewey SL, Schlyler DJ, Macgregor RR et al. (1989). Mapping cocaine binding sites in human and baboon brain in vivo. Synapse 4:371-377.
12. Goeders NE (1997). A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology 22:237-259.
13. Goeders NE, Bienvenu OJ, De Souza EB (1990). Chronic cocaine administration alters corticotropin-releasing factor receptors in the rat brain. Brain Res 531:322-328.
14. Goeders NE, Guerin GF (1994). Non-contingent electric footshock stress increases vulnerability to self-administer cocaine in rats. Psychopharmacology 114:63-70.
15. Goeders NE, Guerin GF (1996). Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of cocaine self-administration in rats. Brain Res 722:145-152.
16. Goeders NE, Guerin GF (1997). Effects of ketoconazole on intravenous cocaine self-administration in rats. NIDA Research Monograph 178, 180.
17. Goland RS, Conwell IM, Warren WB, Wardlaw SL (1992). Placental corticotropin-releasing hormone and pituitary-adrenal function during pregnancy. Neuroendocrinology 56:742-749.
18. Griffiths RR, Bigelow GE, Liebson I, Kaliszak JE (1980). Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo. J Pharmacol Exp Ther 215:649-661.
19. Harfstrand A, Fuxe K, Cintra A, Agnati LF, Zini I, Wikstorm A et al. (1986). Glucocorticoid receptor immunoreactivity in monoaminergic neurons in rat brain. Proc Natl Acad Sci 83:9779-9783.
20. Langlais PJ, Rothschild AJ, Schatzberg AF, Cole JO, Bird ED (1984). Dexamethasone elevates dopamine in human plasma and rat brain. Psychopharmacol Bull 20:365-379.
21. Lupien S, Richter R, Risen SC, Mirow A, Gillin JC, Hauger RL (1995). Time course of the corticosteroid-dopaminergic interactionduring metyrapone and dexamethasone administration. Psychiatry Res 58:23-35.
22. Mantero F, Boscaro M (1992). Glucocorticoid-dependent hypertension. J Steroid Biochem Mol Biol 43:409-413.
23. Mendelson JH, Mello NK, Teoh SK, Ellingboe J, Cochin J (1989). Cocaine effects on pulsatile secretion of anterior pituitary, gonadal, and adrenal hormones. J Clin Endocrin Metabolism 69:1256-1260.
24. Mendelson JH, Teoh SK, Mello NK, Ellingboe J (1992). Buprenorphine attenuates the effects of cocaine on adrenocorticotropine (ACTH) secretion and mood states in man. Neuropsychopharmacology 7:157-162.
25. Moldow RL, Fischman AJ (1987). Cocaine-induced secretion of ACTH, beta-endorphin, and corticosterone. Peptides 8:819-822.
26. Morse AC, Erwin VG, Jones BC (1995). Pharmacogenetics of cocaine: a critical review. Pharmacogenetics 5:183-192.
27. Patel A, Uhl G, Kuhar MJ (1993). Species differences in dopamine transporters: postmortem changes and glycosylation differences. J Neurochemistry 61:496-500.
28. Piazza PV, Barrot M, Rouge-Pont F, Marinelli M, Maccari S, Abrous DN et al. (1996). Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. Proc Nad Acad Sci 93:15445-15450.
29. Piazza PV, Deminiere JM, Le Moal M, Simon H (1990). Stress- and pharmacologically induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res 514:22-26.
30. Piazza PV, Deroche V, Deminiere JM, Maccari S, Le Moal M, Simon H (1993). Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. Proc Natl Acad Sci 90:11738-11742.
31. Piazza PV, Le Moal M (1996). Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids and dopaminergic neurons. Ann Rev Pharmacol Toxicol 36:359-378.
32. Piazza PV, Marinelli M, Jodogne C, Deroche V, Rouge-Pont F, Maccari S et al. (1994). Inhibition of corticosterone synthesis by Metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res 658:259-264.
33. Ramsey NF, Van Ree JM (1993). Emotional but not physical stress enhances intravenous cocaine self-administration in drug-naive rats. Brain Res 608:216-222.
34. Saphier D, Welch JE, Farrar GE, Goeders NE (1993). Effects of intracerebroventricular and intrahypothalamic cocaine on adrenocortical secretion. Neuroendocrinology 57:54-62.
35. Schenk S, Lacelle G, Gorman K, Amit Z (1987). Cocaine self-administration in rats influenced by environmental conditions: implications for the etiology of drug abuse. Neurocsci Lett 81:227-231.
36. Schimmer BP, Parker KL (1996). Adrenocorticotropic hormone; aderenocortical steroids and their synthetic analogs: inhibitors of the synthesis and actions of adrenocortical hormones. In: Goodman and Gilman's the pharmacological basis of therapeutics. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (editors). New York: McGraw-Hill, pp. 1459-1485.
37. Sholar MB, Mendelson JH, Mello NK, Siegel AJ, Kaufman MJ, Levin JM et al. (1998). Concurrent pharmacokinetic analysis of plasma cocaine and adrenocorticotropic hormone in men. J Clin Endocrinol Metabol 83:966-968.
38. Tallarida RJ, Murray RB (1981). Manual of pharmacological calculations with computer programs. New York: Springer Verlag.